A detailed history of Strs Ohio transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Strs Ohio holds 500 shares of BMEA stock, worth $3,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$3,555
Previous $2,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$21.66 - $41.8 $10,830 - $20,900
500 New
500 $10,000
Q1 2022

Apr 21, 2022

SELL
$4.39 - $9.03 $21,950 - $45,150
-5,000 Closed
0 $0
Q4 2021

Jan 24, 2022

BUY
$7.22 - $12.72 $21,660 - $38,160
3,000 Added 150.0%
5,000 $37,000
Q2 2021

Jul 26, 2021

BUY
$13.65 - $20.93 $27,300 - $41,860
2,000 New
2,000 $31,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $208M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.